
Selank Peptide: Complete Guide to the Anxiety Research Peptide
A comprehensive guide to Selank, the synthetic peptide studied for anxiolytic and nootropic effects, including mechanism of action, research findings, and comparison to Semax.
Selank Peptide: Complete Guide
Quick Facts
| Property | Details |
|---|---|
| Full Name | Selank (TP-7) |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Amino Acids | 7 |
| Origin | Tuftsin analog + Pro-Gly |
| Developer | Institute of Molecular Genetics, Russia |
| Primary Effects | Anxiolytic, nootropic |
| Administration | Intranasal, subcutaneous |
| Status | Approved in Russia, research elsewhere |
Table of Contents
- Introduction
- What is Selank
- Mechanism of Action
- Research Findings
- Selank vs Semax
- Administration
- Potential Side Effects
- Frequently Asked Questions
- Conclusion
Introduction
Selank is a synthetic peptide developed in Russia for anxiety and cognitive research. As a tuftsin analog, it combines immunomodulatory properties with anxiolytic effects, making it unique among nootropic peptides.
This guide examines Selank's mechanisms, research findings, and how it compares to related peptides like Semax.
Note: Selank is a research peptide not approved by the FDA for any indication. This article presents research findings for educational purposes.
What is Selank
Origin and Development
Selank was developed at the Institute of Molecular Genetics (Russian Academy of Sciences) by combining:
- Tuftsin (Thr-Lys-Pro-Arg) - Immunomodulatory tetrapeptide
- Pro-Gly-Pro - Stabilizing sequence
Structure
Selank: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Comparison to parent compounds:
Tuftsin: Thr-Lys-Pro-Arg
Selank: Thr-Lys-Pro-Arg-Pro-Gly-Pro
↑
Added for stability
Key Characteristics
| Property | Details |
|---|---|
| Molecular Weight | ~751 Da |
| Stability | More stable than tuftsin |
| Half-life | Minutes (peptide) |
| Solubility | Water-soluble |
| Storage | -20°C lyophilized |
Regulatory Status
| Region | Status |
|---|---|
| Russia | Approved anxiolytic |
| USA | Research compound (not FDA approved) |
| Europe | Research compound |
| Canada | Research compound |
Mechanism of Action
Primary Mechanisms
Selank works through multiple pathways:
1. GABA System Modulation
- Enhances GABA-ergic transmission
- Allosteric modulation of GABA-A receptors
- Does not bind benzodiazepine site
- Non-sedating anxiolytic effect
2. Monoamine Effects
| Neurotransmitter | Effect |
|---|---|
| Serotonin | Modulates metabolism |
| Dopamine | Influences levels |
| Norepinephrine | Affects signaling |
3. BDNF Expression
- Increases Brain-Derived Neurotrophic Factor
- Supports neuroplasticity
- May enhance learning and memory
- Neuroprotective potential
4. Gene Expression
Selank has been shown to affect expression of:
- Anxiety-related genes
- Immune-related genes
- Neurotrophic factors
Immunomodulatory Effects
From its tuftsin heritage:
- Modulates cytokine balance
- Affects T-cell function
- Anti-inflammatory properties
- May support immune regulation
Mechanism Summary
Selank Administration
↓
┌───────┴───────┐
│ │
GABA-ergic Monoamine
Modulation Effects
↓ ↓
Anxiolytic Mood/Cognition
Effects Enhancement
↓
┌───────┴───────┐
│ │
BDNF Immune
Expression Modulation
↓ ↓
Neuroplasticity Anti-inflammatory
Research Findings
Anxiety Research
Animal Studies:
| Model | Findings |
|---|---|
| Elevated plus maze | Reduced anxiety behaviors |
| Open field | Increased exploration |
| Stress models | Improved stress response |
| Learned helplessness | Protective effects |
Human Research (Russian):
- Anxiolytic effects reported
- Comparable to benzodiazepines in some measures
- Without sedation or dependence
- Approved for clinical use in Russia
Cognitive Research
Findings:
- Memory enhancement in animal models
- Improved learning in stress conditions
- Attention modulation
- Neuroprotective effects
Proposed Cognitive Benefits:
- Working memory support
- Stress-resilient cognition
- Focus enhancement
- Memory consolidation
Immunomodulatory Research
Observations:
- Cytokine balance modulation
- T-cell activity effects
- Anti-inflammatory properties
- Potential autoimmune applications (research)
Comparison to Benzodiazepines
| Factor | Selank | Benzodiazepines |
|---|---|---|
| Anxiolytic | Yes | Yes |
| Sedation | No | Yes |
| Dependence | Not reported | Yes |
| Cognitive impairment | No | Yes |
| Tolerance | Not significant | Yes |
| Mechanism | Multiple pathways | GABA-A specific |
Selank vs Semax
Overview Comparison
| Property | Selank | Semax |
|---|---|---|
| Origin | Tuftsin analog | ACTH fragment |
| Primary effect | Anxiolytic | Cognitive enhancer |
| Sequence | 7 amino acids | 7 amino acids |
| Developer | Same institute | Same institute |
| Administration | Nasal/injection | Nasal/injection |
Mechanism Differences
Selank:
- GABA modulation primary
- Anxiolytic focus
- Immunomodulatory
- Calming effect
Semax:
- BDNF/NGF primary
- Cognitive focus
- Neuroprotective
- Stimulating effect
Effects Comparison
| Effect | Selank | Semax |
|---|---|---|
| Anxiety reduction | ●●●●● | ●●●○○ |
| Cognitive enhancement | ●●●○○ | ●●●●● |
| Stimulation | ●○○○○ | ●●●○○ |
| Calming | ●●●●● | ●●○○○ |
| Neuroprotection | ●●●○○ | ●●●●○ |
| Immune modulation | ●●●●○ | ●●○○○ |
Which to Choose
Choose Selank for:
- Primary anxiety focus
- Stress reduction
- Calm without sedation
- Immune support interest
- Sleep issues related to anxiety
Choose Semax for:
- Cognitive enhancement focus
- Focus and attention
- Neuroprotection
- Depression (research)
- Mental clarity
Consider Both:
- Some use both for complementary effects
- Selank for calm, Semax for cognition
- Research interest in combination
Administration
Intranasal Administration
Most common method:
| Factor | Details |
|---|---|
| Concentration | Typically 0.1% solution |
| Dose | 200-400mcg per dose |
| Frequency | 1-3x daily |
| Duration | Cycles of 2-4 weeks |
Technique:
- Tilt head slightly forward
- Insert tip just inside nostril
- Spray while inhaling gently
- Alternate nostrils
- Avoid blowing nose immediately
Subcutaneous Injection
Alternative administration:
| Factor | Details |
|---|---|
| Dose | 250-500mcg |
| Frequency | 1-2x daily |
| Location | Abdomen, arm |
| Duration | Similar cycling |
Reconstitution (If Applicable)
For lyophilized powder:
- Use bacteriostatic water
- Calculate concentration
- Store refrigerated
- Use within 2-4 weeks
Cycling Recommendations
| Approach | Protocol |
|---|---|
| Conservative | 2 weeks on, 1 week off |
| Standard | 3-4 weeks on, 1-2 weeks off |
| Assessment | Start low, evaluate response |
Potential Side Effects
Reported Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Nasal irritation | Common | With intranasal use |
| Fatigue | Occasional | Usually initial |
| Headache | Rare | Typically mild |
| Allergic reaction | Rare | Discontinue if occurs |
Safety Profile
Based on available research:
- Generally well-tolerated
- No significant CNS depression
- No dependence reported
- No cognitive impairment
- Minimal drug interactions known
Contraindications (Proposed)
- Known peptide allergies
- Pregnancy/breastfeeding (unstudied)
- Severe immunocompromise (theoretical)
- Concurrent benzodiazepine use (unknown interactions)
Comparison to Standard Anxiolytics
| Factor | Selank | Benzodiazepines | SSRIs |
|---|---|---|---|
| Addiction potential | None reported | High | Low |
| Sedation | None | High | Variable |
| Onset | Fast | Fast | Weeks |
| Tolerance | Not significant | Develops | Not significant |
| Withdrawal | Not reported | Significant | Possible |
Frequently Asked Questions
How quickly does Selank work?
Effects may be noticed within minutes to hours after administration, unlike SSRIs which take weeks. Optimal effects may develop over days of consistent use.
Is Selank addictive?
No addiction or dependence has been reported in available research, unlike benzodiazepines.
Can Selank be used with other nootropics?
Combinations are sometimes used but lack formal study. Common stacks include Selank with Semax. Caution with other GABA-ergic substances.
How does Selank compare to prescription anxiolytics?
Selank shows anxiolytic effects in research without the sedation, dependence, or cognitive impairment of benzodiazepines. However, it lacks FDA approval and extensive Western clinical trials.
What's the difference between Selank and NA-Selank?
NA-Selank (N-Acetyl Selank) is an acetylated form claimed to have improved stability and potency. Limited comparative research exists.
Is Selank legal?
In most countries, Selank is legal to purchase for research purposes. It's not a controlled substance but is not approved for human medical use outside Russia.
How should Selank be stored?
Lyophilized: -20°C for long-term Reconstituted: 2-8°C, use within 2-4 weeks Protect from light and moisture
Can Selank help with social anxiety?
Some research suggests anxiolytic effects that could apply to social anxiety, though specific studies on social anxiety are limited.
Conclusion
Selank represents an interesting approach to anxiety research, combining anxiolytic effects with immunomodulatory properties. Its mechanism differs substantially from traditional anxiolytics, potentially offering benefits without typical side effects.
Summary
| Aspect | Assessment |
|---|---|
| Mechanism | Multi-target (GABA, monoamines, BDNF) |
| Primary use | Anxiolytic research |
| Research level | Moderate (more needed outside Russia) |
| Safety profile | Favorable in available research |
| Comparison | Different from but complementary to Semax |
Key Points
- Developed from tuftsin with added stability
- Anxiolytic without sedation or dependence (research)
- Multiple mechanisms beyond GABA alone
- Immunomodulatory properties from tuftsin heritage
- Research compound outside Russia
Research Needs
- More Western clinical trials
- Long-term safety data
- Standardized protocols
- Comparative studies
- Combination research
Selank remains an active area of nootropic and anxiolytic research with promising early findings.
References
-
Semenova TP, et al. Effects of Selank on cognitive processes after damage to the cerebral catecholamine system during early ontogenesis. Bull Exp Biol Med. 2009.
-
Zozulya AA, et al. The anxiolytic effect of Selank. Bull Exp Biol Med. 2001.
-
Kozlovskii II, et al. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior. Neurosci Behav Physiol. 2003.
-
Uchakina ON, et al. Immunomodulatory effects of Selank. Bull Exp Biol Med. 2008.
-
Seredenin SB, et al. Selank peptide derivative with anxiolytic activity. Vopr Med Khim. 1998.
-
Kolik LG, et al. Comparison of Selank anxiolytic action with benzodiazepine effects. Bull Exp Biol Med. 2014.
Reviewed by: Dr. Research Reviewer, PhD